Clinical Research Directory

Inclusion Criteria: * Age ≥ 18 years; * Unresectable stage III or stage IV melanoma according to the AJCC classification - 8th edition; * Curative immunotherapy treatment (anti-PD-1 and/or anti-CTLA-4); * Treatment and follow-up at the Dermatology Department of the Strasbourg University Hospitals; * Immunotherapy initiated between January 1, 2013, and December 31, 2021. Exclusion Criteria: * Primary choroidal melanoma; * Adjuvant-intent immunotherapy; * Less than 3 months of follow-up after the start of immunotherapy; * Change of treatment before the first reassessment; * Treatment and follow-up at a department other than the Dermatology Department of the Strasbourg University Hospitals.